Obuya Sarah, Elkholy Amr, Avuthu Nagavardhini, Behring Michael, Bajpai Prachi, Agarwal Sumit, Kim Hyung-Gyoon, El-Nikhely Nefertiti, Akinyi Pamela, Orwa James, Afaq Farrukh, Abdalla Mohammed, Michael Anwar, Farouk Mohamed, Bateman Lori Brand, Fouad Mona, Saleh Mansoor, Guda Chittibabu, Manne Upender, Arafat Waleed
Moi Teaching and Referral Hospital, Moi University, Kesses, Kenya.
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
J Gastrointest Oncol. 2022 Oct;13(5):2282-2292. doi: 10.21037/jgo-22-116.
Colorectal cancer (CRC) is the fifth most diagnosed cancer in Sub-Saharan Africa. In Kenya, CRC incidence rates tripled from 1997 to 2017. In the Moi Teaching and Referral Hospital, Moi University, there has been an increase in CRC cases, notably for younger patients. A suggested pathobiology for this increase is gut microbiome dysbiosis. Since, for the Kenyan CRC patient population, microbiome studies are rare, there is a need for a better understanding of how microbiome dysbiosis influences CRC epidemiology in Kenya. In this single-center study, the focus was on profiling the gut microbiome of Kenyan CRC patients and healthy volunteers and evaluating associations between microbiome profiles and the age of CRC patients.
The gut mucosa-associated microbiome of 18 CRC patients and 18 healthy controls were determined by 16S rRNA sequencing and analyzed for alpha and beta diversity, differential abundance, and microbial metabolic profiling.
Alpha diversity metrics showed no significant differences, but beta diversity metrics showed dissimilarities in the microbial communities between CRC patients and healthy controls. The most underrepresented species in the CRC group were () and (), although () and were overrepresented (linear discriminant analysis, LDA score >2, P<0.05). Also, for CRC patients, significant metagenomic functional alterations were evident in microbial glutamate metabolic pathways (L-glutamate degradation VIII was enriched, and L-glutamate and L-glutamine biosynthesis were diminished) (P<0.05, log2 Fold Change >1). Moreover, the microbiome composition was different for patients under 40 years of age compared to older patients (LDA score >2, P<0.05).
Microbiome and microbial metabolic profiles of CRC patients are different from those of healthy individuals. CRC microbiome dysbiosis, particularly and depletion and glutamate metabolic alterations, are evident in Kenyan CRC patients.
结直肠癌(CRC)是撒哈拉以南非洲地区第五大最常被诊断出的癌症。在肯尼亚,从1997年到2017年,结直肠癌发病率增长了两倍。在莫伊大学莫伊教学与转诊医院,结直肠癌病例有所增加,尤其是年轻患者。这种增加的一种推测病理生物学机制是肠道微生物群失调。由于针对肯尼亚结直肠癌患者群体的微生物群研究很少,因此有必要更好地了解微生物群失调如何影响肯尼亚的结直肠癌流行病学。在这项单中心研究中,重点是分析肯尼亚结直肠癌患者和健康志愿者的肠道微生物群,并评估微生物群谱与结直肠癌患者年龄之间的关联。
通过16S rRNA测序确定18例结直肠癌患者和18例健康对照的肠道黏膜相关微生物群,并分析其α和β多样性、差异丰度以及微生物代谢谱。
α多样性指标无显著差异,但β多样性指标显示结直肠癌患者和健康对照之间的微生物群落存在差异。结直肠癌组中代表性最不足的物种是()和(),尽管()和()的代表性过高(线性判别分析,LDA得分>2,P<0.05)。此外,对于结直肠癌患者,微生物谷氨酸代谢途径中存在明显的宏基因组功能改变(L-谷氨酸降解VIII富集,L-谷氨酸和L-谷氨酰胺生物合成减少)(P<0.05,log2倍数变化>1)。此外,40岁以下患者与老年患者的微生物群组成不同(LDA得分>2,P<0.05)。
结直肠癌患者的微生物群和微生物代谢谱与健康个体不同。在肯尼亚结直肠癌患者中,明显存在结直肠癌微生物群失调,尤其是()和()的减少以及谷氨酸代谢改变。